Calidi Biotherapeutics CEO Allan Camaisa sells $16,200 in inventory By Investing.com
SAN DIEGO—Allan Camaisa, CEO and Chairman of the Board at Calidi Biotherapeutics,…
Sonnet BioTherapeutics studies advances in most cancers remedy drug By Investing.com
PRINCETON, NJ - Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: NASDAQ:), a clinical-stage biotech…
Oppenheimer units $12 goal on SAB Biotherapeutics shares By Investing.com
On Tuesday, Oppenheimer initiated protection on SAB Biotherapeutics (NASDAQ:SABS) with an Outperform…
